Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Basic
8
Ṁ185
2027
43%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against non-small-cell lung carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
and
S3.00
Sort by:

I think this is second most likely to get approval - very high market demand, high mutational load, already approved for checkpoint inhibitor therapy.

© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules